| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
Papers In Press, published online ahead of print January 16, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immunology, The Scripps Research Institute, La Jolla, CA 82037
Corresponding Author: lcurtiss{at}scripps.edu
Atherosclerosis is a chronic inflammatory response characterized by the accumulation of cells of innate and acquired immune systems within the intima of the arterial wall. Macrophages are the predominant participant in innate immune responses in atherosclerosis. Protein receptors expressed by macrophages and endothelial cells recognize components and products of microorganisms and play a vital role in innate immunity. In particular the members of the toll-like receptor or TLR family play a critical role in the inflammatory components of atherosclerosis. Both exogenous ligands involved in microbial recognition as well as endogenous ligands involved in sterile inflammation pathways are implicated in the pathology of atherosclerosis. In this review we discuss our current understanding of the role of TLRs and their co-activators in atherosclerosis with particular emphasis on studies in atherosclerosis-prone hypercholesterolemic mice.
Revised on January 5, 2005
Accepted on January 7, 2005
Paying the price for pathogen protection: toll receptors in atherogenesis
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Erridge, S. Kennedy, C. M. Spickett, and D. J. Webb Oxidized Phospholipid Inhibition of Toll-like Receptor (TLR) Signaling Is Restricted to TLR2 and TLR4: ROLES FOR CD14, LPS-BINDING PROTEIN, AND MD2 AS TARGETS FOR SPECIFICITY OF INHIBITION J. Biol. Chem., September 5, 2008; 283(36): 24748 - 24759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Catellier, N. Aleksic, A. R. Folsom, and E. Boerwinkle Atherosclerosis Risk in Communities (ARIC) Carotid MRI Flow Cytometry Study of Monocyte and Platelet Markers: Intraindividual Variability and Reliability Clin. Chem., August 1, 2008; 54(8): 1363 - 1371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Knapp, S. von Aulock, M. Leendertse, I. Haslinger, C. Draing, D. T. Golenbock, and T. van der Poll Lipoteichoic Acid-Induced Lung Inflammation Depends on TLR2 and the Concerted Action of TLR4 and the Platelet-Activating Factor Receptor J. Immunol., March 1, 2008; 180(5): 3478 - 3484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Fitzner, S. Clauberg, F. Essmann, J. Liebmann, and V. Kolb-Bachofen Human Skin Endothelial Cells Can Express All 10 TLR Genes and Respond to Respective Ligands Clin. Vaccine Immunol., January 1, 2008; 15(1): 138 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A Mitchell, M. J Paul-Clark, G. W Clarke, S. K McMaster, and N. Cartwright Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease J. Endocrinol., June 1, 2007; 193(3): 323 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Into, Y. Kanno, J.-i. Dohkan, M. Nakashima, M. Inomata, K.-i. Shibata, C. J. Lowenstein, and K. Matsushita Pathogen Recognition by Toll-like Receptor 2 Activates Weibel-Palade Body Exocytosis in Human Aortic Endothelial Cells J. Biol. Chem., March 16, 2007; 282(11): 8134 - 8141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cappello, B. Saugel, K. C. Huth, A. Zwergal, M. Krautkramer, C. Furman, M. Rouis, B. Wieser, H. W. Schneider, D. Neumeier, et al. Ozonized Low Density Lipoprotein (ozLDL) Inhibits NF-{kappa}B and IRAK-1-Associated Signaling Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 226 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-q. Yan Regulation of TLR4 Expression Is a Tale About Tail. Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2582 - 2584. [Full Text] [PDF]
|
|
|
|
|
|
U. Singh, S. Devaraj, M. R. Dasu, D. Ciobanu, J. Reusch, and I. Jialal C-Reactive Protein Decreases Interleukin-10 Secretion in Activated Human Monocyte-Derived Macrophages via Inhibition of Cyclic AMP Production Arterioscler. Thromb. Vasc. Biol., November 1, 2006; 26(11): 2469 - 2475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Trogan, J. E. Feig, S. Dogan, G. H. Rothblat, V. Angeli, F. Tacke, G. J. Randolph, and E. A. Fisher Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. PNAS, March 7, 2006; 103(10): 3781 - 3786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Katz and R. P. Shannon Bacteria and Coronary Atheroma: More Fingerprints but No Smoking Gun Circulation, February 21, 2006; 113(7): 920 - 922. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Chamorro and J. Hallenbeck The Harms and Benefits of Inflammatory and Immune Responses in Vascular Disease Stroke, February 1, 2006; 37(2): 291 - 293. [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Getz Bridging the innate and adaptive immune systems J. Lipid Res., April 1, 2005; 46(4): 619 - 622. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |
